Cargando…
Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis
Rheumatoid arthritis is a chronic autoimmune disease, with the features of recurrent chronic inflammation of synovial tissue, destruction of cartilage, and bone erosion, which further affects joints tissue, organs, and systems, and eventually leads to irreversible joint deformities and body dysfunct...
Autores principales: | Zhang, Yanyan, Gao, Zhaoju, Chao, Shushu, Lu, Wenjuan, Zhang, Pingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246099/ https://www.ncbi.nlm.nih.gov/pubmed/35757855 http://dx.doi.org/10.1080/10717544.2022.2089295 |
Ejemplares similares
-
Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis
por: Xu, Yuyi, et al.
Publicado: (2023) -
Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
por: Liu, Songlin, et al.
Publicado: (2023) -
Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
por: Cao, Jian, et al.
Publicado: (2019) -
Transdermal delivery of triptolide–phospholipid complex to treat rheumatoid arthritis
por: Liu, Xin-Yi, et al.
Publicado: (2021) -
Promising Strategies for Transdermal Delivery of Arthritis Drugs: Microneedle Systems
por: Wang, Jitong, et al.
Publicado: (2022)